Amyvid (florbetapir F-18)

florbetapir · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Amyvid (florbetapir F-18), covering 2016-08-17 to 2022-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography [Phase 4]